Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling ampk'

Search results for: 'research area pi3k akt signaling ampk'

Items 21-30 of 94

Page
per page
  1. CHIR-99021 (CT99021) HCl
    A8396 CHIR-99021 (CT99021) HCl
    Target: GSK-3
    Summary: GSK-3α/β inhibitor
      ≥25.1 mg/mL
  2. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL
  3. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL
  4. Miltefosine
    B1371 Miltefosine
    Target: PI3K
    Summary: PI3K/Akt inhibitor
      ≥10.2 mg/mL
  5. Wnt-C59
    A8685 Wnt-C59
     2 Citation
    Target: PORCN
    Summary: PORCN inhibitor,highly potent and selective
      .95 mg/mL
      insoluble in H2O; ≥18
  6. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL
  7. SB 203580
    A8254 SB 203580
     9 Citation
    Target: p38|PKB
    Summary: P38 MAP kinase inhibitor
      insoluble in H2O; ≥18.872 mg/mL
  8. ICG 001
    A8217 ICG 001
     1 Citation
    Summary: Wnt/β-catenin pathway inhibitor
      ≥27.43 mg/mL
  9. Duvelisib (IPI-145, INK1197)
    A1720 Duvelisib (IPI-145, INK1197)
    Target: PI3K
    Summary: PI3K-δ/PI3K-γ inhibitor
      ≥20.84 mg/mL
  10. LDN-193189
    A8324 LDN-193189
    Target: BMP and Other Activin Receptors
    Summary: ALK inhibitor,potent and selective
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O

Items 21-30 of 94

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Histone Deacetylases (HDACs) 1 item
  2. Akt 5item
  3. PI3K 21item
  4. Raf 6item
  5. mTOR 10item
  6. Androgen Receptors 1 item
  7. GSK-3 5item
  8. P-glycoprotein (P-gp) 1 item
  9. PLK 1 item
  10. VEGFR 3item
  11. PDGFR 1 item
  12. Phosphodiesterases (PDEs) 1 item
  13. p38 4item
  14. PKB 1 item
  15. JNK 2item
  16. MEK 4item
  17. PORCN 1 item
  18. FGFR 1 item
  19. GABAB Receptors 1 item
  20. Smoothened 1 item
  21. STAT 4item
  22. EGFR 2item
  23. Hedgehog 1 item
  24. BMP and Other Activin Receptors 2item
  25. JAK 2item
  26. Syk 1 item
  27. DNA-PK 4item
  28. HSP90 1 item
  29. AMPK 4item
  30. TNKS 1 item
  31. Toll-like receptors (TLRs) 1 item
  32. ERK 1 item
  33. PKC 3item
  34. Melanocortin (MC) Receptors 1 item
  35. Fatty-acid-binding proteins (FABPs) 1 item
  36. NO Donors / Precursors 1 item
  37. IL Receptors 1 item
  38. PKD 1 item
  39. ATM 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Bladder Cancer 1 item
  4. Breast Cancer 23item
  5. Cancer 65item
  6. Cervical Cancer 2item
  7. Cholangiocarcinoma 1 item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Colon Cancer 10item
  10. Colon Carcinoma 1 item
  11. Colorectal Cancer 11item
  12. Glioblastoma 10item
  13. Glioma 4item
  14. Hepatocellular Carcinoma 1 item
  15. Leukemia 6item
  16. Liver Cancer 1 item
  17. Lung Cancer 7item
  18. Lymphoma 2item
  19. Melanoma 6item
  20. Multiple Myeloma 1 item
  21. Myeloma 1 item
  22. Neuroblastoma 2item
  23. Non-small Cell Lung Cancer 6item
  24. Ovarian Cancer 7item
  25. Pancreatic Cancer 9item
  26. Pancreatic Carcinoma 2item
  27. Prostate Cancer 11item
  28. Pulmonary Arterial Hypertension 1 item
  29. Pulmonary Fibrosis 1 item
  30. Renal Cancer 2item
  31. Rheumatoid Arthritis 2item
  32. Thyroid Cancer 2item
  33. Type 2 Diabetes 2item